{"nct_id":"NCT03145181","title":"Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2017-05-16","start_date_type":"ACTUAL","primary_completion_date":"2021-11-09","primary_completion_date_type":"ACTUAL","completion_date":"2027-05-28","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["JNJ"]}